(Q42359993)

28 October 2017

Initial sulfonylurea use and subsequent insulin therapy in older subjects with type 2 diabetes mellitus (English)

1 reference

28 October 2017

1 reference

1 reference

Alex Z Fu

1

1 reference

28 October 2017

Ying Qiu

series ordinal

2

1 reference

28 October 2017

Michael J Davies

series ordinal

3

1 reference

28 October 2017

Samuel S Engel

series ordinal

4

1 reference

28 October 2017

18 October 2012

1 reference

28 October 2017

1 reference

28 October 2017

3

1 reference

28 October 2017

1

1 reference

28 October 2017

12

1 reference

Creative Commons Attribution 2.0 Generic

28 October 2017

start time

18 October 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1007/s13300-012-0012-9

0 references

cites work

Pancreatic function, type 2 diabetes, and metabolism in aging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508115

Factors associated with initiation of antihyperglycaemic medication in UK patients with newly diagnosed type 2 diabetes

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508115

Exendin-4 protects against sulfonylurea-induced β-cell apoptosis

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508115

Effects of rosiglitazone, glyburide, and metformin on β-cell function and insulin sensitivity in ADOPT.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508115

Initiation of insulin therapy in elderly patients taking oral antidiabetes drugs

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508115

Loss of glycemic control in patients with type 2 diabetes mellitus who were receiving initial metformin, sulfonylurea, or thiazolidinedione monotherapy

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508115

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508115

Desensitization of insulin secretion

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508115

Oral antihyperglycemic therapy for type 2 diabetes: scientific review

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508115

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508115

Predictors for the initiation of a basal supported oral therapy (BOT) in type 2 diabetic patients under real-life conditions in Germany

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508115

Time to treatment initiation with oral antihyperglycaemic therapy in US patients with newly diagnosed type 2 diabetes

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508115

Time to insulin treatment and factors associated with insulin prescription in Swedish patients with type 2 diabetes.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508115

Secondary sulfonylurea failure: comparison of period until insulin treatment between diabetic patients treated with gliclazide and glibenclamide

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508115

Secondary failure rates associated with metformin and sulfonylurea therapy for type 2 diabetes mellitus

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508115

Sulfonylurea induced beta-cell apoptosis in cultured human islets

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508115

Changes in treatment after the start of oral hypoglycaemic therapy in Type 2 diabetes: a population-based study

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3508115

The central role of the propensity score in observational studies for causal effects

17 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS13300-012-0012-9

U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group

21 January 2018

2 references

Crossref

https://api.crossref.org/works/10.1007%2FS13300-012-0012-9

21 January 2018

https://pubmed.ncbi.nlm.nih.gov/23076984

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Sulfonylurea and glinide reduce insulin content, functional expression of KATP channels, and accelerate apoptotic β-cell death in the chronic phase

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS13300-012-0012-9

Addressing the issue of channeling bias in observational studies with propensity scores analysis

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23076984

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Initial monotherapy with either metformin or sulphonylureas often fails to achieve or maintain current glycaemic goals in patients with Type 2 diabetes in UK primary care

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23076984

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S13300-012-0012-9

1 reference

28 October 2017

1 reference

28 October 2017

1 reference